Overview

A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Status:
Suspended

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This study will look at whether emtricitabine is as safe and effective as abacavir (ABC) when taken with stavudine (d4T) and efavirenz (EFV) in patients who have never taken anti-HIV drugs.

Phase:

Phase 3

Details

Lead Sponsor:

Triangle Pharmaceuticals

Treatments:

Abacavir
Dideoxynucleosides
Efavirenz
Emtricitabine
Stavudine